University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
32 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Maryland (UMD) is a research university that operates with colleges and schools. The university offers academic departments and programs include agricultural and resource economics, American studies, animal and avian sciences, anthropology, applied mathematics and scientific computation program, Arabic studies, behavioral and community health, biochemistry, bioengineering, and chemical physics program, among others. It provides services to college of agriculture and natural resources, school of architecture, planning, and preservation, college of arts and humanities, college of behavioral and social sciences, robert h.

University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on m

  
Source:
Document ID
GDPH123877D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Maryland, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Maryland, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Maryland, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Maryland, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
University of Maryland, Medical Devices Deals, 2010 to YTD 201691
University of Maryland, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
University of Maryland, Pharmaceuticals &Healthcare, Deal Details1216
  Partnerships121
    University of Maryland Enters Into Licensing Agreement With Harpoon Medical121
    ImmunoCellular Therapeutics Enters into Research Agreement with University of Maryland, Baltimore131
    Nosocomial Vaccine Enters into Agreement with Affinivax and University of Maryland141
    University Of Maryland School Of Medicine Enters Into Co-Development Agreement With MRIGlobal Dx151
    University of Maryland School of Medicine Forms Joint Venture With Advanced Particle Therapy162
  Licensing Agreements181
    Educational and Scientific Enters into Licensing Agreement with University of Maryland181
    Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore191
    Rexahn Pharma Enters Into Licensing Agreement With University of Maryland For Nano-Polymer-Drug Conjugate Systems201
    SilcsBio Enters Into Licensing Agreement With UM Ventures211
    Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore221
    University Of Maryland Enters Into Licensing Agreement With Bali BioSciences231
    Sirnaomics Enters Into Licensing Agreement With University of Maryland Medical School241
  Asset Transactions251
    Prolias Acquires Antibody Technology From University of Maryland Biotech Institute251
  Acquisition261
    AE Biofuels Acquires Zymetis262
University of Maryland - Key Competitors281
Key Employees291
Locations And Subsidiaries302
  Head Office301
  Other Locations &Subsidiaries302
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Maryland-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17196>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Maryland - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Maryland-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17196>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research